Sugars as bulking agents to prevent nano-crystal aggregation during spray or freeze-drying

被引:73
作者
Kumar, Sumit [1 ]
Gokhale, Rajeev [2 ]
Burgess, Diane J. [1 ]
机构
[1] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
[2] AbbVie Pte Ltd, Res & Dev, Singapore 138667, Singapore
关键词
Nano-crystalline suspension; Spray-drying; Freeze-drying; Nano-crystal powder; Sugars; DRUG NANOSUSPENSIONS; FORMULATION; BIOAVAILABILITY; HYDROPHOBICITY; NANOPARTICLES; DISSOLUTION; STORAGE;
D O I
10.1016/j.ijpharm.2014.05.060
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the effect of low and high molecular weight sugars on indomethacin nano-crystalline suspension powders prepared by spray or freeze-drying was evaluated. Dowfax 2A1 (negatively charged surfactant) was utilized as indomethacin nanosuspensions stabilizer. Dried crystalline powders with or without sugars were characterized for crystallinity, particle size and powder yield. Interactions between the nanosuspension stabilizer (i.e. Dowfax 2A1) and sugars were investigated by utilizing IR spectroscopy and contact angle measurements. The nanosuspension formulations containing small molecular weight sugars were non-aggregating compared to those containing polysaccharides. Additionally, higher powder yields were observed with formulations containing sugars with higher glass transition temperature during spray drying. The formulations containing low glass transition temperature sugars were sticking to the spray drier glass walls and thus resulted in lower yields. The small molecular weight sugars showed favorable interactions with Dowfax 2A1, as evident by the IR and contact angle data, possibly resulting in minimal nano-crystal aggregation during spray or freeze-drying. A combination of sugars (i.e. small molecular weight and polysaccharides) may be utilized to achieve higher spray-drying yields and non-aggregating nano-crystalline powders. Published by Elsevier B.V.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 22 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]   Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Fessi, Hatem .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 63 (02) :87-94
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]  
Beirowski J., 2010, J PHARM SCI
[5]   Conversion of nanosuspensions into dry powders by spray drying: A case study [J].
Chaubal, Mahesh V. ;
Popescu, Carmen .
PHARMACEUTICAL RESEARCH, 2008, 25 (10) :2302-2308
[6]  
Cheow W.S., 2010, INT J PHARM
[7]   Evaluating real-life high-throughput screening data [J].
Gribbon, P ;
Lyons, R ;
Laflin, P ;
Bradley, J ;
Chambers, C ;
Williams, BS ;
Keighley, W ;
Sewing, A .
JOURNAL OF BIOMOLECULAR SCREENING, 2005, 10 (02) :99-107
[8]   High-throughput drug discovery: what can we exulect from HTS? [J].
Gribbon, P ;
Sewing, A .
DRUG DISCOVERY TODAY, 2005, 10 (01) :17-22
[9]   Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads [J].
Kayaert, Pieterjan ;
Anne, Michael ;
Van den Mooter, Guy .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (11) :1446-1453
[10]  
Kumar S., 2012, LONG ACT INJECT IMPL